Ingevity Corp (Symbol: NGVT) shares recently surpassed the average analyst 12-month target price of $70.75, trading at $72.17 per share. This development prompts analysts to reassess their projections, which currently include a range from $65.00 to $77.00, with a standard deviation of $4.924.
As of now, there are three strong buy ratings and two hold ratings for NGVT, with no sell or strong sell ratings recorded. The average rating stands at 1.8, where 1 signifies a strong buy and 5 a strong sell. Investors are encouraged to evaluate whether the stock’s recent increase indicates further growth potential or if it has reached a valuation peak.
